Welcome to the State of California 

Antimicrobial Resistance

The Centers for Disease Control and Prevention (CDC) estimates more than 2 million illnesses and 23,000 deaths are attributable to antimicrobial-resistance infections in the United States each year. Infections with resistant organisms are more difficult to treat and are associated with prolonged hospital stays and greater disability and death compared with infections caused by susceptible organisms. There are currently few antibiotics left in the treatment arsenal against resistant infections and even fewer new drugs in the development pipeline.
In the CDC's Antibiotic Resistance Threats in the United States, 2013 Report, two healthcare-associated pathogens, Clostridium difficile (C. difficile) and carbapenem-resistant Enterobacteriaceae (CRE), are highlighted as requiring Urgent attention. These organisms are considered high-consequence threats because of multiple factors, including minimal progress in past efforts to decrease C. difficile infections and the lack of available treatment options for many CRE infections.

Click here for more information on CDI:

CDI Image

Click here for more information on CRE:

CRE Image

Click here for more information on MRSA:

Core actions to prevent resistance include improving antimicrobial prescibing through stewardship, reducing infections, and preventing transmission of resistant bacteria.

Click here for more information on Antimicrobial Stewardship:

Antimicrobial Stewardship Image

Click here for more information on Infection Prevention Resources:

IP Resources for Education Image

Click here for more information on National and International Campaigns:

IP Resources for Education Image

 

 
 
Last modified on: 9/10/2014 3:06 PM